Efficacy and Safety of AP Collagen Peptide on the Skin

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
This double-blinded, randomized, placebo-controlled study aimed to evaluate the efficacy and safety of AP collagen peptides (APCP) containing 3% Glycine-Proline-Hydroxyproline (GPH) on improving skin health. Subjects with dried skin were randomly assigned to receive placebo or APCP once daily for 12 weeks.
Epistemonikos ID: ba09efcd35f5a7a7d8a4bf80ab64c77f095dbcba
First added on: May 09, 2024